Cobimetinib is a targeted therapy for melanoma with BRAF V600E/K mutation. The dosage per treatment cycle and treatment cost are key concerns for patients. This article provides a detailed analysis of the standard dosage, treatment cost structure, and special considerations for special populations, offering comprehensive guidance for patients.
Number of Boxes of Cobimetinib per Treatment Cycle
Accurate calculation of cobimetinib dosage per cycle is critical for treatment planning and medication procurement, requiring precise calculation based on the standard regimen.
Standard Treatment Regimen
The recommended dose of cobimetinib is 60 mg daily (3 tablets of 20 mg each), administered on a 28‑day cycle consisting of 21 days of treatment followed by 7 days off treatment. Under this regimen, one cycle requires 63 tablets of 20 mg strength, which corresponds exactly to the quantity in one box.
Duration of Treatment
Treatment is generally continued until disease progression or unacceptable toxicity. Clinical data indicate that most patients require 4–6 cycles to assess treatment response, meaning at least 4–6 boxes should be prepared.
Dosage Adjustment
If dosage reduction is needed due to adverse reactions, the dose may be adjusted to 40 mg/day or 20 mg/day, allowing one box to last longer. However, initial procurement is still recommended based on the standard dose to maintain treatment continuity.
Cost of One Treatment Cycle of Cobimetinib
Understanding the cost of cobimetinib helps patients with financial planning. Cost calculation depends on drug price, number of cycles, and other factors.
Price per Box
Cobimetinib produced by Lao Da Xiong is available as 20 mg × 63 tablets per box, with a market price of approximately 355 US dollars. The drug is not yet approved in China and must be imported through formal channels.
Cost per Standard Treatment Cycle
Based on 4–6 cycles, the total cost ranges from about 1,420 to 2,130 US dollars. Actual cost may vary due to exchange rate fluctuations, shipping fees, and other factors.
Cost‑Saving Suggestions
Patients may follow patient assistance programs or updates to medical insurance policies. Since cobimetinib is not yet covered by Chinese medical insurance, advance financial planning is recommended for fully self‑funded patients. Only formal procurement channels should be used to avoid counterfeit products.
